Neurocrine Biosciences
NBIX
#1345
Rank
NZ$28.41 B
Marketcap
NZ$282.64
Share price
-2.07%
Change (1 day)
35.43%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Quarterly Reports

Thumbnail Neurocrine Biosciences
 Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report